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Preliminary findings have indicated that in naturally infected
sheep, fully susceptible to scrapie (vRQ-homozygous), PrPSc
can be detected in the tonsils approximately one year before
the expected onset of clinical disease, whereas no immuno-
staining can be detected in animals with a semi-resistant geno-
type. This paper describes the technique for taking tonsillar
biopsies from sheep and gives the results of the completed
experiment. In another experiment PrPsc was detected even
earlier in comparable vRQ-homozygous sheep born and raised
in different surroundings. At three-and-a-half months of age
no PrpSC could be detected in three homozygous susceptible
sheep (VRQ/VRQ), but Prpsc was detected at four months in one
similar sheep. At eight months of age all seven sampled
VRQ/VRQ sheep showed positive immunostaining in the biop-
sies, but none of the biopsies from three VRQ/ARQ heterozy-
gotes showed any immunostaining; they were positive when
sampled at 14 to 15 months of age. Biopsies from VRQ/ARR
sheep were negative throughout this period. On the basis of
the established or expected incubation period, PrPSc could thus
be detected in the tonsils of live susceptible animals at between
one-third and a half of the incubation period, more than one-
and-a-half years before clinical signs normally appear in both
these genotypes.
THE recent recognition that there is a link between bovine spongi-
form encephalopathy (BSE) in cattle and a new variant of
Creutzfeldt-Jakob disease (v-CJD) in human beings (Will and others
1996, Bruce and others 1997, Hill and others 1997a) highlights the
urgent need to find a method for the preclinical diagnosis of trans-
missible spongiform encephalopathies (TSES), or prion diseases.
The preliminary results of an experiment which could lead to an
early preclinical diagnostic method for scrapie and possibly for
other TSES, using tonsillar biopsies and scrapie in sheep as a
model, have recently been reported by Schreuder and others
(1996). This study observed that in sheep with a genetically deter-
mined high susceptibility and born in a flock where natural
scrapie occurred, the disease-associated form of the prion protein,
PrpSc, could be detected in the tonsils approximately one year
before the expected onset of clinical disease. This paper describes
the procedure for taking tonsillar biopsies from sheep and gives
the results of the completed experiment.
The search for a practical preclinical diagnostic test for TSES
continues to be a main topic of research. Because TSE-infected ani-
mals and humans have neither a disease-specific immune response
nor consistent biochemical, haematological, or gross pathological
abnormalities associated with the disease, early diagnosis depends
on the recognition of clinical signs, electroencephalography or
magnetic resonance imaging techniques, or the more invasive
method of taking brain biopsies.
Confirmatory diagnosis of TSES still depends on the histological
examination of the brain of suspected cases. The neuropathologi-
cal lesions, mainly consisting of vacuolation (spongiform change)
of the grey matter associated with gliosis and neuronal loss, are
generally sufficiently characteristic. Further confirmation can be
obtained by demonstrating the presence of scrapie associated fib-
rils, PrpSc, or infectivity. Infectivity is detected in a mouse bioas-
say, but this, in spite of being the most sensitive detection method
available, is too cumbersome and time-consuming ever to become
a practical diagnostic method. Numerous studies have confirmed
PrpSc as a sensitive and specific marker for TSEs (Prusiner 1992).
PrpSc is detected by immunochemical techniques such as Western
blotting or immunohistochemistry. The latter technique has
become an accepted diagnostic tool for diagnosing clinical CJD,
scrapie and BSE, and is less cumbersome than Western blotting.
In attempts to develop an early detection method, similar tech-
niques have been applied to blood, urine, tissue fibroblasts and,
particularly in the animal field, to lymphoid tissue. Most of these
attempts have given either negative or inconclusive results
(Schreuder 1994). Reports have started to appear of the presence
of disease-specific proteins in cerebrospinal fluid (CSF) (Hsich and
others 1996). They were based on work done in the 1980s by
Harrington and others (1986), in which brain proteins of the 14-3-3
group were related to the presence of CJD. The initial optimism
about the use of CSF in clinical cases of BSE (Jones and others
1996, Lee and Harrington 1997) has declined and, because the
markers are probably connected with pathological changes in the
central nervous system itself, it is unlikely that this approach will
be successful in preclinical stages, though it may have potential in
the early clinical stages (Jones and others 1996).
Hadlow and colleagues (1980, 1982) used a mouse bioassay to
show that infectivity was detectable in the lymphoid tissue of nat-
urally infected scrapie sheep as early as 10 to 14 months of age,
well before it occurred in the central nervous system (cNs). From
this work, the present authors concluded that lymphoid tissues
offered the best possibilities for the development of a preclinical
test based on the detection of PrpSc. This was further corroborated
by the immunohistochemical examination of a range of lymphoid
tissues from a group of 55 naturally infected, clinically positive
scrapie sheep (confirmed histologically at postmortem) in which
PrPSc was detected in the spleen, retropharyngeal lymph nodes,
mesenteric lymph nodes and palatine tonsils, in all but one of the
animals (van Keulen and others 1996). The tonsils were found to
have the highest 'infection rate' per follicle; in 93 per cent of the
sheep with scrapie, more than 80 per cent of the follicles stained
positive for PrpSc. For this reason, and because they are relatively
easily accessible, the tonsils appeared to offer the best prospect
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for a preclinical diagnostic test. Sequential biopsies were therefore
taken from the tonsils of two groups of sheep of known geno-
types, born and raised at two different locations but both in a
scrapie-infected environment, and they were examined immuno-
histochemically.
Materials and methods
Animals
Experiment A. - Eleven purpose-bred lambs predominantly of the
Swifter breed, a synthetic breed built up from crosses from
Flemish and Texel breeds, were used. Seven lambs were homozy-
gous for the PrPVRQ allele (with the residue valine [VI at position
136 of the ovine PrP amino acid sequence, arginine [R] at position
154, and glutamine [Q] at position 171). The remaining four
lambs were heterozygous, possessing one PrPVRQ allele and one
PrPARR allele (with alanine [A] at position 136 and arginine [R] at
positions 154 and 171). The PrPVRQ allele has been found to be sig-
nificantly associated with an increased susceptibility to scrapie in
several breeds of sheep including that used in this experiment,
whereas the PrPARR allele is significantly associated with increased
resistance to scrapie (Belt and others 1995). The 11 lambs were
born and raised on a farm where scrapie had been occurring for
several years. In this flock it was observed that sheep with the
genotype PrPVRQNRQ died from scrapie when they were about 25
months old (range 23 to 29 months) (Bossers and others 1996),
but that most of the sheep with the genotype PrPVRQ/ARR were still
healthy at 70 months. Maintained in this environment, the
prpVRQ/vRQ sheep would be expected to develop signs of disease at
about 25 months old, whereas the PrPVRQ/ARR sheep should remain
healthy and serve as negative controls. These two groups of sheep
were therefore regarded as a suitable model for studying changes
at known stages of the incubation period.
The lambs were transferred to the ID-DLO at six months old.
Tonsillar biopsies were taken sequentially from 10 of the 11 ani-
mals, starting at about nine months of age, with intervals of about
three months between biopsies in the susceptible sheep. One ani-
mal served as an additional control to assess the incubation peri-
od; it was not biopsied and was allowed to incubate the disease
naturally.
Experiment B. - The lambs used in experiment B were Swifter x
Texel crossbreds and were, unlike those in experiment A, born
and raised on ID-DLO premises. On these premises, scrapie sus-
pected animals from all over the Netherlands have been gathered,
suspected and positive ewes have lambed, and scrapie has been
occurring for several years. Eleven purpose-bred lambs were
selected, seven of them homozygous for the PrPVRQ allele. The
remaining four lambs were heterozygous; three of them were of
the genotype PrPVRQ/ARQ, and the other had one PrPVRQ allele and
one PrPARH allele (with histine [HI at position 171 instead of glu-
tamine).
In the breeds investigated in the Netherlands, the PrPARQ allele is
associated with an intermediate susceptibility to scrapie, whereas
the PrPARH allele is not significantly associated with increased
resistance or susceptibility (Belt and others 1995). Under the con-
ditions of experiment A, animals with the VRQ/ARQ genotype were
expected to become clinically positive at about three years of age
(Bossers and others 1996).
Tonsillar biopsies were taken at irregular intervals, starting at
an age of about four months in the homozygous animals and at
eight months in the heterozygous animals.
Tonsillar biopsy
The sheep were anaesthetised by the intravenous administration
of a combination of 4 to 8 mg/kg ketamine-HCl (Ketalar; Alfasan
NL), 0-05 mg/kg xylazine (Rompun; Bayer) and 0-1 mg/kg
atropine. Alternatively, medetomidine-HCl (Domitor; SmithKline
Beecham) at a rate of 0.1 to 0 14 ml/10 kg was used, which allows
the use of the antidote atipamezole (Antisedan; SmithKline
Beecham) at 0.1 ml/10 kg. As experience in performing the biop-
sy increased, anaesthesia became unnecessary in the younger,
more easily handled animals, reducing the time involved in the
collection of a sample to less than five minutes. Using full anaes-
thesia took about 15 minutes and required the usual precautions
during recovery. The biopsy was collected by using a mouth gag,
a laryngoscope, and biopsy forceps. A headlamp helped to make it
easier to see the tonsils. The tongue was depressed with the laryn-
goscope and a pinch biopsy was taken from the edge of the
entrance to the palatine tonsil.
Rectal biopsy forceps, as used in human medicine, with a head
approximately 4 mm in diameter were used. The biopsy material
was fixed in 10 per cent neutral buffered formalin (4 per cent
formaldehyde). The forceps were decontaminated between uses
by exposure to 3 M sodium hydroxide for at least one hour, fol-
lowed by two cycles of porous-load autoclaving for 60 minutes at
134°C. A more detailed account of the technique of taking a ton-
sillar biopsy has been given by Schreuder and others (1997).
In sheep, the tonsils are encrypted, surrounding a small cavity,
the tonsillar sinus. A biopsy from the edge of the entrance (usually
more than one entrance is visible) to the sinus usually yields suffi-
cient lymphoid follicular material to be examined. With more than
80 per cent of the follicles staining positive in a large majority of
the confirmed clinical scrapie cases, a minimum number of three
follicles was estimated to be sufficient for a proper assessment.
Samples immunostained for the presence of PrPSC could thus have
three possible interpretations:
1) positive: immunostaining indicating the presence of PrPSc, in
any number of follicles;
2) negative: no detectable immunostaining in at least three folli-
cles;
3) inconclusive: less than three follicles in the sample with no
detectable immunostaining.
PrPSc immunohistochemistry
Details of the immunoperoxidase staining method for PrPSc,
using antibodies directed against selected, synthetic, ovine PrP-
based peptides, have been described for staining brain sections
(van Keulen and others 1995) and lymphoid tissue sections (van
Keulen and others 1996). Slight changes have been made to the
latter procedure. The tonsillar biopsy material was fixed in 10 per
cent buffered formalin for four to six hours, 5 pm thick sections,
mounted on silane-coated glass slides, were dried for at least 48
hours at 37°C and deparaffinised. After pretreatment with formic
acid for 30 minutes and hydrated autoclaving, the sections were
immunostained with the antipeptide antiserum R52 1, which is
raised in rabbits and based on the ovine PrP sequence 94 to 105.
As substrate for the peroxidase reaction, diaminobenzidine
(Sigma) was used and 0 1 M imidazole was added to darken and
increase the intensity of the staining. Sections were mounted in
Eukitt (Kindler).
Results
Experiment A
Homozygous susceptible sheep. - As previously reported by
Schreuder and others (1996), clear, extensive PrPSC immunostain-
ing was found in tonsillar biopsies from all six sampled suscepti-
ble PrPVRQNRQ sheep, collected for the first time at approximately
10 months of age (range nine-and-a-half to 10 months), when
none of the sheep showed clinical signs of scrapie (Fig la). Four
of the six susceptible animals were removed from the group at 10,
13, 17 and 20 months of age for the bioassay of tonsils (results not
yet available) but the remaining two were allowed to incubate the
disease fully (numbers 1994 and 2005). They were both killed at
26 months of age, after having shown clear signs of scrapie for
one and one-and-a-half months (Fig 2a). The one susceptible
/1148
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FIG 1: a) Positive PrPSC immunostaining in lymphoid follicles in a tonsillar biopsy from a scrapie-susceptible sheep (PrPVRQ/VRQ) aged 10
months. Peroxidase-labelled streptavidin-biotin staining. b) Negatively staining tonsillar biopsy from a PrPVRQ/ARR sheep of the same age. Bar =
100 pm
PrPVRQNRQ sheep which was not biopsied (2008) was also killed at
26 months, after having shown signs of scrapie for about two
months.
The clinical signs in the last three animals included progressive
emaciation and pruritus, and in the final stages of the disease, fine
tremors were noted. Scrapie was confirmed by standard histologi-
cal procedures of brain sections and by immunohistochemistry.
For all the susceptible animals, immunostaining in the tonsillar
biopsies remained positive throughout their respective observation
periods and PrPSC was detected in the tonsils in all cases (Fig 2a).
Heterozygous resistant sheep. - No PrPSC immunostaining was
detected in biopsies from any of the four resistant PrPVRQ/ARR
sheep (Fig lb). Two of them were killed at 24 months of age and
examined for the presence of PrPSC in a number of lymphoid tis-
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sheep have remained negative in the tonsils (Fig 2b) (presently 34
months).
Experiment B
Homozygous susceptible sheep. - Three of four samples collected
at three-and-a-quarter to three-and-a-half months contained suffi-
cient lymphoid follicles to allow interpretation (animals 2838,
2847 and 2848); no PrPSC immunostaining was detected in any of
them. Two animals were sampled later in the first round, one at an
age of exactly four months (animal 2863) and one at five months
(animal 2839) (after two inconclusive samples): both showed pos-
itive PrPSC immunostaining. These two were removed from the
group for confirmation of infectivity by bioassay. The remaining
five susceptible PrPVRQNRQ lambs were successfully sampled in a
second round at seven-and-a-half to eight months, all with posi-
tive results (Fig 3a).
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Tonsillar biopsies from these animals remained positive from
then on, during their respective observation periods. In all cases
PrpSc was detected in the tonsils postmortem. Clinical signs
indicative of scrapie have so far not been observed in the two
sheep allowed to incubate the disease fully (animals 2838 and
2848) after 18 months of observation.
Heterozygous susceptible sheep. - The four heterozygous lambs
were sampled at longer intervals. When sampled for the first time
at about eight months of age, none of the three PrPVRQ/ARQ lambs
showed any PrPSC immunostaining in the tonsillar biopsies.
However, two were positive at 14 months (animals 2837 and
2840), and the third was positive at 15 months and three weeks
(animal 2842) (Fig 3b).
The lamb with genotype PrPVRQ/ARH (animal 2849) did not show
any PrPSC immunostaining at nine months, but after two inconclu-
sive samplings it was found positive at 16 months and one week
old. So far no clinical signs of scrapie have been detected in this
group after 18 months.
Discussion
The results of experiments A and B demonstrate that in this
model a reliable diagnosis of scrapie could be made in live ani-
mals incubating the disease, at less than half the incubation peri-
od. The animals in the two experiments were born and raised at
two different locations, at which scrapie had been present for sev-
eral years. The expected incubation period for PrPVRQNRQ homozy-
gous animals was confirmed under the conditions of experiment
A. Two regularly sampled PrPVRQ/VRQ animals and one additional
PrPVRQ/VRQ sheep that had not been biopsied in experiment A were
allowed to incubate the disease fully and were killed at 26 months
of age, after having shown clear signs of scrapie for one to two
months. The procedure of collecting biopsies did not appear to
interfere with the length of the incubation period. The survival
time of these three animals was consistent with previous findings
on the incubation period for this susceptible genotype in an infect-
ed environment (range 23 to 29 months) (Bossers and others
1996). Two PrPVRQNRQ animals from experiment B were also
allowed to incubate the disease fully, they are 18 months old and
still healthy.
In experiment A, the scrapie associated PrPSC was detected in
the tonsils of sheep at about 10 months of age, which is less than
half the expected and now confirmed incubation period of about
two years, and more than one year before the onset of clinical dis-
ease. This PrPSC protein was not -detected in sheep expected to
develop scrapie at a much later stage or in animals expected to
remain healthy throughout their lives. It should be stressed that a
PrpSC-negative tonsillar biopsy does not imply that an animal is
free of infection (see also below).
Because there was already extensive PrPSC staining in the sus-
ceptible PrPVRQ/VRQ animals in the first samples taken at about 10
months of age, accumulation of PrPSC had probably started earli-
er in this genotype. This was demonstrated in experiment B, in
which the data obtained in experiment A were reproduced in
sheep born and raised at a different location. In addition, it was
shown that in the tonsils of fully susceptible animals there was
no detectable accumulation of PrPSC for at least the first three
months. All the tested PrPVRQNvRQ animals accumulated PrPSC in
their tonsils at seven to eight months of age, at about 30 per cent
of the expected incubation period. The data from animals 2863
and 2839 suggest that this accumulation started even earlier,
between four and five months, which is at about 20 per cent of
the expected incubation period. Too few sheep were biopsied
between four and seven months, however, to draw firm conclu-
sions about when PrPSc begins to accumulate.
In the heterozygous susceptible PrpVRQ/ARQ animals, PrPSc was
detected in the tonsils at 14 to 16 months of age whereas no PrPSc
accumulation was detectable at eight months of age. These ani-
mals are expected to become clinically positive at about three
years old, and the present results indicate their tonsils were
already positive at less than 50 per cent of the expected incubation
period. More intensive sampling between nine and 14 months
might have yielded a more accurate 'conversion period' for this
genotype.
There was a difference in the time of appearance of PrPSc in the
biopsies from the vRQ-homozygous and vRQ-heterozygous ani-
mals; at eight months of age positive results were found in all the
PrPVRQNRQ animals but in none of the PrPVRQ/ARQ or PrPvRQ/ARH
animals, which had all been bom and raised under the same con-
ditions. From experimental work with scrapie strains injected
intraperitoneally into different strains of mice, it was concluded
that the incubation periods depend mainly on the dynamics of the
replication of the agent within the nervous system and not the
lymphoreticular system (Kimberlin and Walker 1988), because
the nervous system had in all cases been invaded within a few
days or weeks. Kimberlin (1990) suggested that the innate resis-
tance of certain genotypes could also be due to a barrier prevent-
ing or delaying the invasion of the CNS. From the above differ-
ence in temporal development in the lymphoid tissue, it can be
concluded that - under the circumstances of a natural infection -
at least part of the relative resistance or susceptibility lies in
events at the level of the lymphoreticular system or earlier in the
pathogenesis. Such events may have a molecular basis in the
gene-dose effect, that is the fact that vRQ-homozygous animals
have double the expression level of the PrPVRQ allele, compared
with the heterozygous animals.
Application to scrapie control
Because immunohistochemistry is a standard procedure in most
research and routine diagnostic laboratories, these results could
have several applications in the field of diagnosing TSES, particu-
larly with respect to future control programmes for scrapie.
Control programmes could consist of a combination of breeding
programmes that make use of the linkage between PrP genotype
and increased resistance for scrapie, and the above method that
detects the pathognomonic presence of PrPSc in the tonsils of
infected animals in the preclinical stage. Screening tonsillar tis-
sues will yield far more positive cases than any technique using
brain material or markers formed by changes in the CNS, because
the changes start much earlier in the tonsil and, furthermore,
remain positive throughout the remainder of the incubation period
- even when the infectivity level may have dropped (Hadlow and
others 1974).
Further research should define at what stage the tonsils become
positive in the various other PrP genotypes and breeds, under dif-
ferent conditions of infective load and different strains of the
agent. Once this information has been established, tonsillar biop-
sies combined with genotyping could be used to determine the
infection status of a flock by sampling a representative number of
selected sheep with susceptible genotypes. In the authors' opinion
this would be a more accurate method for establishing a flock's
freedom from infection than other methods, for example farmers'
statements on the absence of clinical signs or monitoring the
scrapie status by a histopathological examination of one brain per
hundred animals per year.
A possible drawback was the earlier finding that the tonsils from
one of 55 clinically positive animals did not stain positively for
PrPSC (van Keulen and others 1996); the animal had a semi-resistant
genotype ( PrPVRQ/ARR) and no positive immunostaining was found
in the tonsils in spite of it having had clinical and histopathologi-
cally confirmed scrapie. A similar result was obtained by Western
blotting techniques of spleen samples from various experimentally
infected sheep (Somerville and others 1997); the same genotype
escaped detection in the spleen when the animals had been inocu-
lated by the intracerebral route, but not when they had been inocu-
lated subcutaneously. In the same study, other genotypes inoculat-
ed with the notorious isolate CH1641 and animals challenged orally
with BSE-infected material, proved mostly negative in the spleens.
Conversely, in another study infectivity and PrPSc were detected in
the spleens of sheep infected orally with BSE (Foster and others
1996, Somerville and others 1997), but unfortunately the tonsils
were not available for immunohistochemistry.
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Proper validation is therefore required with regard to these
varying conditions, after which the test may be suitable for the
routine screening of slaughter animals, although it would need to
be converted into a rapid and sensitive antigen detection assay for
use on homogenised tissue.
Application to other TSEs
BSE. - The BSE agent is not distributed as widely in tissues outside
the CNS as is the scrapie agent in sheep; experimental transmission
to mice succeeded only when brain and other CNS material was
used (Fraser and others 1988, 1991) and mice inoculated with
other materials, including lymphoid tissue, remained healthy
(Fraser and Foster 1994). The distal ileum has been added to the
list of BSE-positive materials, but this was after a massive oral
challenge (Wells and others 1994). These largely negative results
may have favourable implications for the assessment of the risks
to consumers, but the prospects for a preclinical test for BSE using
less invasive techniques than, for example brain biopsies, are less
favourable. However, the bioassay of infectivity may also be less
sensitive for BSE than for scrapie.
What has been said about infectivity also applies to the pres-
ence of PrpSC; in clinical cases of BSE in cattle, PrPSC has so far
been detected only in brain material and other parts of the CNS,
and not in the spleen, lymph nodes or white blood cells (Farquhar
and others 1994). The present technique was therefore unlikely to
work in the case of BSE. However, because the immunohistochem-
ical technique had not been tried in depth in the preclinical stages
of BSE (Mohri and others 1992), and because BSE might behave
like experimental scrapie infection in goats, with the infectivity
disappearing from the lymphatic tissues (Hadlow and others
1974), and because the mouse bioassay might not be sensitive
enough for various non-neural tissues of BSE-infected cattle, it was
considered worth investigating. The tonsillar tissues from the two
clinically positive and histologically confirmed cases of BSE in the
Netherlands were examined, but no PrPSC immunostaining was
detected in the samples (L. J. M. van Keulen, unpublished obser-
vations).
Creutzfeldt-Jakob disease (cJD). - Schreuder and others (1996)
indicated that their test was likely to be applicable to human TSES
such as CJD or v-CJD, because infectivity had been detected in vari-
ous lymphoid tissues of patients with classical CJD (Brown and
others 1994) and tonsillar biopsy is a relatively non-invasive, sim-
ple technique. Its applicability has been confirmed in a clinical
case of v-CJD, albeit in material obtained postmortem (Hill and
others 1997b).
A diagnosis made less than halfway through the incubation
period undoubtedly has advantages, but the possibility of early
detection also has adverse implications; if the tonsils of CJD
patients should, as in the case of scrapie, prove to harbour the
disease-specific form of PrP long before the clinical signs have
developed, there would be a danger of iatrogenic transmission
not only in neurosurgery, but also in 'simple' surgical procedures
like tonsillectomies.
For the immediate future the major contribution of this test will
undoubtedly be in the field of scrapie diagnosis in live susceptible
sheep, for which it is - apart from the bioassay in mice - the only
true preclinical test, with the disease being detected at least one-
and-a-half years before clinical signs develop. Although these
results indicate the presence of infectivity (or at least PrPSC) in the
lymphoid tissues of scrapie-infected sheep less than 12 months
old, the age that was stipulated for public health measures
(Commission Decision 1997), it is not suggested that this age
should be reduced. It should be taken into account that the study
was intentionally carried out with the genotype that had the short-
est incubation period, a genotype that is expected to be rare in
field material.
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